B형 간염 환자에서 Lamivudine과 Adefovir 병용처방으로 유발된 이명의 증례보고
Lamivudine- and Adefovir-Induced Tinnitus in a Patient with Hepatitis B: A Case Report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Lamivudine and adefovir are medications used to treat hepatitis B. We observed the occurrence of tinnitus after administering lamivudine and adefovir to a 49-year-old hepatitis B patient for two months. The patienthad no comorbidities and no history of ear diseases, including tinnitus, and was not taking any other medications. In general, neither lamivudine nor adefovir are known to induce tinnitus as an adverse reaction. A literature search revealed that this is the first case in which tinnitus occurred after lamivudine and adefovir were administered to a hepatitis B patient. Therefore, we believe that this case is clinically valuable and decided to report it.
Abstract
Lamivudine and adefovir are medications used to treat hepatitis B. We observed the occurrence of tinnitus after administering lamivudine and adefovir to a 49-year-old hepatitis B patient for two months. The patienthad no comorbidities and no history of ear diseases, including tinnitus, and was not taking any other medications. In general, neither lamivudine nor adefovir are known to induce tinnitus as an adverse reaction. A literature search revealed that this is the first case in which tinnitus occurred after lamivudine and adefovir were administered to a hepatitis B patient. Therefore, we believe that this case is clinically valuable and decided to report it.
참고문헌 (12)
- Pluda JM, "A phase I", II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infection, 1995, pp.171, 1438~1447
- Nevens F, "Lamivudine therapy for chronic hepatitis B : a six-month randomized doseranging study", Gastroenterology, 113, pp.1258~1263 (1997)
- Perry CM, "Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection", Drugs, 53, pp.657~680 (1997)
- Fung J, "Nucleoside", nucleotide analogues in the treatment of chronic hepatitis B, 2011, pp.66, 2715~2725
- Jayasekara D, "Antiviral therapy for HIV patients with renal insufficiency", J Acquir Immune Defic Syndr, 21, pp.384~395 (1999)
- Epivir-HBV® (lamivudine) tablets and oral solution prescribing information, "GlaxoSmithKline", Research Triangle Park, ~ (2007)
- Carr A, "Adverse effects of antiretroviral therapy", Lancet, 356, pp.1423~1430 (2000)
- Cundy KC, "Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir", Clin Pharmacokinet, 36, pp.127~143 (1999)
- De Clercq E, "Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections", Clin Microbiol Rev, 16, pp.569~596 (2003)
- Hepsera® (adefovir dipivoxil) tablet prescribing information, "Gilead Sciences", Foster City, ~ (2008)
- Simdon J, "Ototoxicity associated with use of nucleoside analog reverse transcriptase inhibitors : a report of 3 possible cases and review of the literature", Clin Infect Dis, 32, pp.1623~1627 (2001)
- Eser Karlidag G, "The effects of pegylated interferon", lamivudine therapy on auditory functions in patients with chronic hepatitis B, 2011, pp.38, 312~318